-
Mashup Score: 4You Have Chosen … Poorly: Why Drug Developers Make Bad Decisions - TimmermanReport.com - 16 day(s) ago
Drug development remains an incredibly expensive endeavor. Much of the cost can be attributed to late-stage clinical trial failures. The burden is borne first and foremost by clinical trial participants who aren’t helped by the experimental medicine. It also significantly impacts the companies sponsoring these studies. Everyone would like to improve the chances that a… Read More
Source: timmermanreport.comCategories: General Medicine NewsTweet
-
Mashup Score: 0
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
Source: timmermanreport.comCategories: General Medicine NewsTweet-
Can you improve your health without obsessing about it? My latest @timmermanreport https://t.co/Sifl9l8A8b . #longevity @wellness @fittinsider @DrMJoyner @hjluks
-
-
Mashup Score: 0
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
Source: timmermanreport.comCategories: General Medicine NewsTweet-
Can you improve your health without obsessing about it? My latest @timmermanreport https://t.co/Sifl9l8A8b . #longevity @wellness @fittinsider @DrMJoyner @hjluks
-
-
Mashup Score: 0
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
Source: timmermanreport.comCategories: General Medicine NewsTweet-
Can you improve your health without obsessing about it? My latest @timmermanreport https://t.co/Sifl9l8A8b . #longevity @wellness @fittinsider @DrMJoyner @hjluks
-
-
Mashup Score: 0
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
Source: timmermanreport.comCategories: General Medicine NewsTweet-
Can you improve your health without obsessing about it? My latest @timmermanreport https://t.co/Sifl9l8A8b . #longevity @wellness @fittinsider @DrMJoyner @hjluks
-
-
Mashup Score: 5The Future of AI and Health, Part III: Improving Health By Enhancing Agency - TimmermanReport.com - 22 day(s) ago
Part II of this series is here “Agency,” Harvard’s Zak Kohane and I agree, is the word of 2025. Kohane’s reasoning: “Patients understand how to increase their agency in their disease journey with often correct and thoughtful instant second opinions from AI.” This perspective aligns with the opportunities described by A16z VCs Vijay… Read More
Source: timmermanreport.comCategories: General Medicine NewsTweet-
Finally, my favorite, Part III (https://t.co/d3qz7qNQqA) of @timmermanreport AI+health series focuses on foundational role of human agency in health, esp work of @PennPosPsychCtr's M Seligman, + insights on genAI for pts from @zakkohane, @goldbergcarey. + impl for @peloton, etc. https://t.co/F0UoaQZ0y0
-
-
Mashup Score: 1Why I Left European Science - TimmermanReport.com - 24 day(s) ago
Monday was my last day as a group leader at The Francis Crick Institute. I got my job at the Crick in 2020, almost exactly 5 years ago, right as COVID was beginning. I had finished my PhD in 2019, and had always told myself that I would only ever be an academic if I… Read More
Source: timmermanreport.comCategories: General Medicine NewsTweet-
RT @ldtimmerman: Why I Left European Science. By @SGRodriques https://t.co/CONGrLWatN
-
-
Mashup Score: 3New Medical Podcast (Like Winter and the 2024 Red Sox) Offers Bleak Outlook, While Four Books Instill Hope - TimmermanReport.com - 2 month(s) ago
As Bostonians tentatively emerge from the bleak cold of another New England winter and begin to search for signs of spring, we instinctively turn to the Red Sox. Unfortunately, I am informed by my daughters that the team’s prospects appear dismal this season, so we’ll need to look elsewhere for hope. We might consider instead… Read More
Source: timmermanreport.comCategories: General Medicine News, General HCPsTweet-
I've discussed @DavidFajgenbaum's inspirational story about his (pre-AI) battle to cure his own disease that he poignantly describes in his book, Chasing My Cure -> https://t.co/HFGWhkt5S1 ; deliberate repurposing historically seductive & elusive, hopefully AI will push forward https://t.co/U6jNSmEgPh
-
-
Mashup Score: 1Sluggish Corporate AI Adoption Has Motivated Entrepreneurs To Pick Their Spots - TimmermanReport.com - 2 month(s) ago
As economic historian Carlota Perez has described, there is typically a significant time lag between when the promise of novel technology begins to emerge and the productive deployment of this technology at scale; TR readers will recall the discussion here from June 2023. Today, we are seeing this with generative AI, an emerging technology that… Read More
Source: timmermanreport.comCategories: General Medicine News, General HCPsTweet-
Sluggish adoption of AI by large cos incl big pharmas has prompted eager AI investors & entreps to capture AI's value by delivering not tools but rather the implementation (& hopefully, assoc AI advantages) itself-my latest @timmermanreport https://t.co/ELZ6HPyfMa @zakkohane
-
-
Mashup Score: 4Defend the NIH - TimmermanReport.com - 3 month(s) ago
Too many people don’t believe anymore in the American Dream. But if you can’t dream big, you can’t accomplish big things. Today, the National Institutes of Health — biomedical science itself — is under attack. It needs us to stand up in its defense. The NIH is an engine of the American Dream. The NIH,… Read More
Source: timmermanreport.comCategories: General Medicine News, Hem/OncsTweet-
BTW, the ‘big dog’ should have 5-10x what it currently has but needs to eliminate waste, inefficiency, and a toxic environment due to low pay-lines. Defend the NIH https://t.co/k0o0lmw0Bh
-
Exactly this sort of poor decision making discussed here: https://t.co/30LjubP2Ln w characteristically penetrating insights from @sciencescanner (and others)… https://t.co/iQ6FYVP9Uj